News

In a response to Encysive’s request for a formal dispute resolution on its new drug application for Thelin, the FDA’s reviewer agreed with the decision of the Division

The Phase III trial of 956 patients is designed to compare the overall survival of patients taking Sutent (sunitinib) in combination with Tarceva (erlotinib) with those taking erlotinib

Data from the Phase III trial showed that at 12 months AGI-1067 delivered only a minor reduction in glycated hemoglobin A1c, a commonly used measure of glycemic control.

Picoplatin is currently being studied in the pivotal Phase III SPEAR (study of picoplatin efficacy after relapse) trial in small cell lung cancer (SCLC), which is evaluating overall

Akela says the results demonstrated statistically significant differences compared to placebo in the measured primary and secondary efficacy variables, resulting in faster and superior pain relief. Fentanyl Taifun

The two new indications approved for Cubicin (daptomycin) were right-sided infective endocarditis (RIE) due to staphylococcus aureus (S. aureus), an infection of the heart valve, and S. aureus

The double-blind, placebo controlled cross-over study of two doses of EVT 201 (1.5mg and 2.5mg) in 67 completed patients was conducted in sleep labs in the US using

The data, which included records from October 1997 to June 2005, were generated from a retrospective analysis of a medical database of anonymous patient records entered by general

In the study, Provecta will be injected into up to 20 tumors in each subject. Additional treatment with Provecta may be made 8 to 16 weeks after this